Physicians at the UAB Pain Treatment Clinic are offering a new treatment for chronic low back pain. The treatment focuses on stimulating one of the key stabilizing muscles of the lumbar spine, the ...
DUBLIN--(BUSINESS WIRE)--Mainstay Medical today announced that the United States Centers for Disease Control and Prevention (CDC) has designated an International Classification of Diseases, Tenth ...
Mainstay Medical Holdings plc has won U.S. FDA approval for its Reactiv8 implantable neurostimulation device. The company is eyeing a commercial launch of the system in early 2021. The FDA approved ...
“This is a totally new way of treating back pain,” said Prentiss Lawson Jr., M.D., an associate professor in the UAB Department of Anesthesiology and Perioperative Medicine and program director of the ...
Non-specific severe long-term chronic refractory low back pain can present in various ways, including as neuropathic pain (associated with damage to the nervous system) or nociceptive pain (associated ...